Compounds > salicylic acid

salicylic acid and plx4032

salicylic acid has been researched along with plx4032 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gómez Fernández, C; Nieto Rodríguez, D; Rueda Carnero, JM	1
Gerami, P; Martini, M; Sorrell, J	1
Arenberger, P; Arenbergerova, M; Fialova, A; Horazdovsky, J; Mrazova, I; Sticova, E	1

Other Studies

3 other study(ies) available for salicylic acid and plx4032

Article	Year
Facial spiny follicular hyperkeratosis induced by vemurafenib. The Journal of dermatology, 2018, Volume: 45, Issue:2 Topics: Aged; Antineoplastic Agents; Diagnosis, Differential; Face; Female; Humans; Keratosis; Melanoma; Salicylic Acid; Skin; Skin Neoplasms; Treatment Outcome; Urea; Vemurafenib; Warts	2018
Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib. Journal of the American Academy of Dermatology, 2012, Volume: 67, Issue:6 Topics: Dermoscopy; Dysplastic Nevus Syndrome; Humans; Indoles; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Scalp; Skin Neoplasms; Sulfonamides; Vemurafenib	2012
Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:5 Topics: Antineoplastic Agents; Biopsy; Female; Humans; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Scalp; Skin; Skin Neoplasms; Stevens-Johnson Syndrome; Treatment Failure; Vemurafenib	2017